Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy

References

• Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601–11
   PubMed Web of Science ®Google Scholar
• Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013;99:63. doi: 10.1016/j.fertnstert.2012.09.023
   PubMed Web of Science ®Google Scholar
• Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes 2009;16:446–50
   PubMed Web of Science ®Google Scholar
• Clarke B, Kirby DR. Maintenance of histocompatibility polymorphisms. Nature 1966;211:999–1000
   PubMed Web of Science ®Google Scholar
• Beer AE, Quebbeman JF, Ayers JW, Haines RF. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 1981;141:987–99
   PubMed Web of Science ®Google Scholar
• Beer AE, Kwak JY. Immunology of normal pregnancy. Immunol Allergy Clin North Am 1998;18:249–70
   Google Scholar
• Sollinger HW, Burlingham WJ, Sparks EM, et al. Donor-specific transfusions in unrelated and related HLA-mismatched donor-recipient combinations. Transplantation 1984;38:612–15
   Google Scholar
• Chaouat G, Kiger N, Wegmann TG. Vaccination against spontaneous abortion in mice. J Reprod Immunol 1983;5:389–92
   PubMedGoogle Scholar
• Taylor C, Faulk WP. Prevention of recurrent spontaneous abortions with leukocyte transfusion. Lancet 1981;2:68–70
   PubMed Web of Science ®Google Scholar
• Agrawal S, Pandey MK, Pandey A. Prevalence of MLR blocking antibodies before and after immunotherapy. J Hematother Stem Cell Res 2000;9:257–62
   Google Scholar
• Kwak JY, Gilman-Sachs A, Moretti M, et al. Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 1998;40:352–8
   Google Scholar
• Yokoo T, Takakuwa K, Ooki I, et al. Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 2006;85:1452–8
   Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4 + CD25 + T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005;166:811–22
   PubMed Web of Science ®Google Scholar
• Caetano MR, Couto E, Passini Jr R, et al. Gestational prognostic factors in women with recurrent spontaneous abortion. Sao Paulo Med J 2006;124:181–5
   Google Scholar
• Mowbray SF, Gibbons C, Lidell H, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985;1:941–3
   PubMed Web of Science ®Google Scholar
• Ober C, Karrison T, Odem RR, et al. Mononuclear-cell immunization in prevention of recurrent miscarriages: a randomized trial. Lancet 1999;354:365–9
   PubMed Web of Science ®Google Scholar
• Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006;19:CD000112
   Google Scholar
• The Recurrent Miscarriage Immunotherapy Trialists Group, Coulam CB, Clark DA, Collins J, et al. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:55–72
   Google Scholar
• Clark DA. Shall we properly re-examine the status of allogeneic lymphocyte therapy for recurrent early pregnancy failure? Am J Reprod Immunol 2004;51:7–15
   PubMed Web of Science ®Google Scholar
• Takeshita T. Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: is paternal lymphocyte immunization a relic of the past? J Nippon Med Sch 2004;71:308–13
   Google Scholar
• Abbassi-Ghanavati M. Thyroid autoantibodies and pregnancy outcomes. Clin Obstet Gynecol 2011;54:499–505
   Google Scholar
• Iijima T, Tada H, Hidaka Y, et al. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997;90:364–9
   PubMed Web of Science ®Google Scholar
• Ticconi C, Giuliani E, Veglia M, et al. Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 2011;66:452–9
   PubMed Web of Science ®Google Scholar
• Shankarkumar U, Pradhan VD, Patwardhan MM, et al. Autoantibody profile and other immunological parameters in recurrent spontaneous abortion patients. Niger Med J 2011;52:163–6
   PubMedGoogle Scholar
• Ticconi C, Rotondi F, Veglia M, et al. Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol 2010;64:384–92
   PubMed Web of Science ®Google Scholar
• Bustos D, Moret A, Tambutti M, et al. Autoantibodies in Argentine women with recurrent pregnancy loss. Am J Reprod Immunol 2006;55:201–7
   PubMed Web of Science ®Google Scholar
• Pandey MK, Thakur S, Agrawal S. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 2004;269:161–72
   PubMedGoogle Scholar
• Gharesi-Fard B, Zolghadri J, Foroughinia L, et al. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA). Iran J Immunol 2007;4:173–8
   PubMedGoogle Scholar
• Nonaka T, Takakuwa K, Ooki I, et al. Results of immunotherapy for patients with unexplained primary recurrent abortions-prospective non-randomized cohort study. Am J Reprod Immunol 2007;8:530–6
   Google Scholar
• Di Renzo GC, Giardina I, Rosati A, et al. Maternal risk factors for preterm birth: a country-based population analysis. Eur J Obstet Gynecol Reprod Biol 2011;159:342–6
   PubMed Web of Science ®Google Scholar